Crossmark

Impact of prior PARP inhibitor exposure on the efficacy of platinum-based chemotherapy in platinum-sensitive recurrent ovarian cancer: a propensity score-matched analysis

Crossref DOI link: https://doi.org/10.1007/s10147-026-03019-w

Published Online: 2026-03-26

Published Print: 2026-06

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Takahashi, Yoshifumi https://orcid.org/0000-0003-3319-1205
Takadera, Miku

Jwa, Seung Chik

Koyanagi, Takahiro

Saga, Yasushi

Takei, Yuji

Fujiwara, Hiroyuki
License Information

Text and Data Mining valid from 2026-03-26

Version of Record valid from 2026-03-26
More Information

Article History

Received: 19 December 2025

Accepted: 17 March 2026

First Online: 26 March 2026

Declarations

:

: The authors have no relevant financial or non-financial interests to disclose.

: The study protocol was approved by the Ethics Committee of Jichi Medical University (Institutional Review Board No. 25-009).

: Due to the use of anonymized clinical data, written informed consent from patients was not obtained. Instead, an opt-out method was used through public disclosure of the study information.

Document is current

Any future updates will be listed below